Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice

Infection and Immunity

Volumn 66, Issue 7, 1998, Pages 3059-3065

  Johnson, David E ^a,b,d   Lockatell, C Virginia ^a   Russell, Robert G ^a   Hebel, J Richard ^a   Island, Michael D ^a   Stapleton, Ann ^c   Stamm, Walter E ^c   Warren, John W ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CYSTITIS; ESCHERICHIA COLI; MOUSE; NONHUMAN; PRIORITY JOURNAL; PYELONEPHRITIS; STRAIN DIFFERENCE;

EID: 0031813836     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.7.3059-3065.1998     Document Type: Article

References (40)

1. Aronson, M., O. Medalia, L. Schori, D. Mirelman, N. Sharon, and I. Ofek. 1979. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside. J. Infect. Dis. 139:329-332.
2. Arthur, M., C. E. Johnson, R. H. Rubin, R. D. Arbeit, C. Campanelli, C. Kim, S. Steinbach, M. Agarwal, R. Wilkinson, and R. Goldstein. 1989. Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Eschericlna coli. Infect. Immun. 57:303-313.
3. Busch, R., and J. Huland. 1984. Correlation of symptoms and results of direct bacterial localization in patients with urinary tract infections. J. Urol. 132:282-285.
4. Cox, C. E., and F. Hinman. 1961. Experiments with induced bacteriuria, vesical emptying and bacterial growth on the mechanism of bladder defense to infection. J. Urol. 86:739-748.
5. Dalal, E., O. Medalia, O. Harari, and M. Aronson. 1994. Moderate stress protects female mice against bacterial infection of the bladder by eliciting uroepithelial shedding. Infect. Immun. 62:5505-5510.
6. Eykyn, S., R. W. Lloyd-Davies, K. E. Shuttleworth, and J. Vinnicombe. 1972. The localization of urinary tract infection by ureteric catheterization. Investig. Urol. 9:271-275.
7. Ferry, S., L. G. Burman, and S. E. Holm. 1988. Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand. J. Infect. Dis. 20:535-544.
8. Gillon, G., M. Small, O. Medalia, and M. Aronson. 1984. Sequential study of bacterial clearance in experimental cystitis. J. Med. Microbiol. 18:319-326.
9. Hagberg, L., I. Engberg, R. Freter, J. Lam, S. Olling, and C. Svanborg Edén. 1983. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect. Immun. 40:273-283.
10. Hull, R. A., R. E. Gill, P. Hsu, B. H. Minshew, and S. Falkow. 1981. Construction and expression of recombinant plasmids encoding type 1 or D-mannose-resistant pili from a urinary tract infection Escherichia coli isolate. Infect. Immun. 33:933-938.
11. Hultgren, S. J., T. N. Porter, A. J. Schaeffer, and J. L. Duncan. 1985. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect. Immun. 50:370-377.
12. Island, M. D. Personal communication.
13. Johnson, D. E., C. V. Lockatell, M. Hall-Craggs, H. L. T. Mobley, and J. W. Warren. 1987. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients. J. Urol. 138:632-635.
14. Johnson, D. E., C. V. Lockatell, M. Hall-Craggs, and J. W. Warren. 1991. Mouse models of short- and long-term foreign body in the urinary bladder: analogies to the bladder segment of urinary catheters. Lab. Anim. Sci. 41:451-455.
15. Johnson, D. E., R. G. Russell, C. V. Lockatell, J. C. Zulty, and J. W. Warren. 1993. Urethral obstruction of 6 hours or less causes bacteriuria, bacteremia, and pyelonephritis in mice challenged with "nonuropathogenic" Escherichia coli. Infect. Immun. 61:3422-3428.
16. Johnson, D. E., R. G. Russell, C. V. Lockatell, J. C. Zulty, J. W. Warren, and H. L. T. Mobley. 1993. Contribution of Proteus mirabilis urease to persistence, urolithiasis, and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. Immun. 61:2748-2754.
17. Johnson, J. R., T. Berggren, D. S. Newburg, R. H. McCluer, and J. C. Manivel. 1992. Detailed histopathological examination contributes to the assessment of Escherichia coli urovirulence. J. Urol. 147:1160-1166.
18. Jones, B. D., C. V. Lockatell, D. E. Johnson, J. W. Warren, and H. L. T. Mobley. 1990. Construction of a urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 58:1120-1123.
19. Kallenius, G., and R. Molby. 1979. Adhesion of Escherichia coli to human periurethral cells correlated to mannose-resistant agglutination of human erythrocytes. FEMS Microbiol. Lett. 5:295-299.
20. Kallenius, G., S. B. Svenson, R. Molby, B. Cedergren, H. Hultberg, and J. Winberg. 1981. Structure of carbohydrate part of receptor on human uroepithelial cells for pyelonephritogenic Escherichia coli. Lancet ii:604-606.
21. Korhonen, T. K., S. Eden, and C. Svanborg-Eden. 1980. Binding of purified Escherichia coli pili to human urinary tract epithelial cells. FEMS Microbiol. Lett. 7:237-240.
22. Liao, J., K. Tomochika, S. Watanabe, and Y. Kanemasa. 1992. Establishment of a mouse model of cystitis and roles of type 1 fimbriated Escherichia coli in its pathogenesis. Microbiol. Immunol. 36:243-256.
23. Lindstedt, R., G. Larson, P. Falk, U. Jodal, H. Leffler, and C. Svanborg. 1991. The receptor repertoire defines the host range for attaching Escherichia coli strains that recognize globo-A. Infect. Immun. 59:1086-1092.
24. Mabeck, C. E. 1972. Treatment of uncomplicated urinary tract infection in non-pregnant women. Postgrad. Med. J. 48:69-75.
25. Marcus, D. M., and R. Janis. 1970. Localization of glycosphingolipids in human tissues by immunofluorescence. J. Immunol. 104:1530-1539.
26. Massad, G., C. V. Lockatell, D. E. Johnson, and H. L. T. Mobley. 1994. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect. Immun. 62:536-542.
27. Mobley, H. L. T., D. M. Green, A. L. Trifillis, D. E. Johnson, G. R. Chippendale, C. V. Lockatell, B. D. Jones, and J. W. Warren. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
28. Mobley, H. L. T., K. G. Jarvis, J. P. Elwood, D. I. Whittle, C. V. Lockatell, R. G. Russell, D. E. Johnson, M. S. Donnenberg, and J. W. Warren. 1993. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of αGal(1-4)βGal binding in virulence of a wild-type strain. Mol. Microbiol. 10:143-155.
29. Norden, C. W., G. M. Green, and E. H. Kass. 1968. Antibacterial mechanisms of the urinary bladder. J. Clin. Invest. 47:2689-2700.
30. O'Grady, F., and W. R. Cattell. 1966. Kinetics of urinary tract infection. II. The bladder. Br. J. Urol. 38:156-162.
31. O'Hanley, P., D. Lark, S. Falkow, and G. Schoolnik. 1985. Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. J. Clin. Invest. 75:347-359.
32. Roberts, J. A., M. B. Kaak, and E. N. Fussell. 1989. Bacterial adherence in urinary tract infections: preliminary studies in a primate model. Infection 17: 401-404.
33. Roberts, R. A., G. M. Surarez, B. Kaack, G. Kallenius, and S. B. Svenson. 1985. Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux. J. Urol. 133:1068-1075.
34. Sandberg, T., B. Kaijser, G. Lidin-Janson, K. Lincoln, F. Ørskov, I. Ørskov, E. Stokland, and C. Svanborg-Edén. 1988. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J. Clin. Microbiol. 26:1471-1476.
35. Savage, D. C. L., G. Howie, K. Adler, and M. I. Wilson. 1975. Controlled trial of therapy in covert bacteriuria of childhood. Lancet 1:358-361.
36. Siitonen, A., R. Martikainen, R. Ikaheimo, J. Palmgren, and P. H. Makela. 1993. Virulence-associated characteristics of Escherichia coli in urinary tract infection: a statistical analysis with special attention to type 1C fimbriation. Microb. Pathog. 15:65-75.
37. Stapleton, A., S. Moseley, and W. E. Stamm. 1991. Urovirulence determinants in Escherichia coli isolates causing first-episode and recurrent cystitis in women. J. Infect. Dis. 163:773-779.
38. Svanborg-Eden, C., L. A. Hanson, U. Jodal, U. Lindberg, and A. S. Akerlund. 1976. Variable adherence to normal human urinary-tract epithelial cells of Escherichia coli strains associated with various forms of urinary-tract infection. Lancet ii:490-492.
39. Warren, J. W. 1997. Host-parasite interactions and host defense mechanisms, p. 873-893. In R. W. Schrier and C. W. Gottschalk (ed.), Diseases of the kidney, 6th ed., vol. 1. Little, Brown and Company, Boston, Mass.
40. Warren, J. W., E. H. Miller, Jr., B. Fitzpatrick, D. E. DiFranco, E. S. Caplan, J. H. Tenney, and W. C. Anthony. 1983. A randomized, controlled trial of cetoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Rev. Infect. Dis. 5:S173-S180.